Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 6Phase 4 3Phase 1/2 3Phase NA 2Phase EARLY_PHASE1 1Phase 1 1

Status

Completed 34Terminated 14Unknown 6Active not recruiting 6Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 4OTHER_GOV 1NETWORK 1

Study Type

Interventional 6

Sponsor

Cancer Type

Other hematologic neoplasm 4Myeloid 4Sarcoma 2Gastrointestinal 2

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Gastrointestinal Stromal Tumors 2Leukemia, Myeloid, Chronic-Phase 1

Interventions

Cisplatin 130Radiotherapy 94Carboplatin 84Fluorouracil 78Paclitaxel 77Cyclophosphamide 77Gemcitabine 72Capecitabine 66Docetaxel 64Doxorubicin 60Oxaliplatin 58Etoposide 57Leucovorin 49Vincristine 47Chemotherapy, Adjuvant 42Cytarabine 38Dexamethasone 35Drug Therapy 33Bevacizumab 31Epirubicin 29Pemetrexed 27Neoadjuvant Therapy 26Irinotecan 25Tamoxifen 24Prednisone 24Methotrexate 21Rituximab 20Vinorelbine 18Radiotherapy, Intensity-Modulated 18Peripheral Blood Stem Cell Transplantation 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × Unknown × Imatinib Mesylate × Clear all
NCT03515018 2018-05-22

HU

First Affiliated Hospital of Harbin Medical University

Phase 3 Unknown
60 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT02576080 2015-10-15

GIGIST

Assistance Publique Hopitaux De Marseille

Phase 3 Unknown
80 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT00685828 2014-07-04

Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Unknown
946 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01400074 2014-01-13

RE-NICE

Seoul St. Mary's Hospital

Phase 3 Unknown
100 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00297570 2007-10-10

Imatinib Versus Imatinib and Peg-Interferon in Patients With Ph+ CML and Complete Cytogenetic Response After Imatinib Therapy

Sheba Medical Center

Phase 3 Unknown
90 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00327262 2006-06-20

Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase

Central European Leukemia Study Group

Phase 3 Unknown
240 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡